EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Journal of Hematology & Oncology

ISSN 1756-8722 · Springer Science and Business Media LLC

Latest articles

  1. Upfront venetoclax plus quizartinib with low-dose cytarabine or azacitidine in older unfit patients with acute myeloid leukemia: the phase I/II VEN-A-QUI trial

    Juan Miguel Bergua, Pilar Lloret-Madrid, Rebeca Rodríguez-Veiga, Isabel Cano-Ferri, Ferran Vall-llovera, Antonio García-Guiñón, Joaquín Gómez-Espuch, Mercedes Colorado, Ignacio Casas-Avilés, Jordi Esteve, Antonia Sampol, María V. Verdugo, Ágata Almela, Marta Valero, Evelyn Acuña-Cruz, Blanca Boluda, Laura Torres, Joaquín Martínez-López, Eva Barragán, Teresa Cedena, Rosa Ayala, Beatriz Martín-Herreros, Bruno Paiva, David Martínez-Cuadrón, Pau Montesinos

    Published: 2026-11-15DOI: 10.1186/s13045-026-01868-6

  2. A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm

    Lihua E. Budde, Marissa M. Del Real, Joo Song, Tracey Stiller, Yan Wang, Ahmed Aribi, Karamjeet Sandhu, Ryotaro Nakamura, Emanuela C. Marcucci, Jian J. Wu, Kenneth Ng, Mary C. Clark, Brent Wood, Jamie R. Wagner, Jinny Paul, Christine E. Brown, Anthony Stein, Guido Marcucci, M. Suzette Blanchard, Joycelynne Palmer, Stephen J. Forman

    Published: 2026-08-07DOI: 10.1186/s13045-026-01833-3

  3. Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm

    Guillaume Cartron, Isabelle Chaillol, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loïc Ysebaert, Sylvain Choquet, Fabrice Jardin, Jacques-Olivier Bay, François-Xavier Gros, Franck Morschhauser, Cédric Rossi, Thomas Gastinne, Catherine Thieblemont, Magalie Joris, Laure Ricard, Caroline Regny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marcais, Romain Ould-Ammar, Karin Tarte, Camille Laurent, Pierre Sesques

    Published: 2026-07-01DOI: 10.1186/s13045-026-01816-4

  4. Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis

    Nico Gagelmann, Hermann Einsele, Sarah Flossdorf, Samih Smaili, Klaus Metzeler, Christoph Scheid, Lars Bullinger, Sandra Sauer, Marc Raab, Justus Duyster, Hans Christian Reinhardt, Raphael Teipel, Winfried Alsdorf, Claudia Lengerke, Wolfgang Herr, Natalie Schub, Francis Ayuketang Ayuk, Florian Bassermann, Christian Schultze-Florey, Roland Schroers, Mathias Hänel, Nicola Giesen, Ahmet Elmaagacli, Andreas Burchert, Thomas Weber, Dimitrios Mougiakakos, Stefan Knop, Fabian Müller, Nicolaus Kröger, Maximilian Merz

    Published: 2026-05-20DOI: 10.1186/s13045-026-01806-6

Volumes

2026 · 842025 · 1182024 · 1322023 · 1232022 · 1782021 · 2062020 · 1742019 · 1452018 · 1432017 · 1752016 · 1382015 · 1312014 · 952013 · 942012 · 832011 · 542010 · 512009 · 572008 · 27

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.